Agilent this week introduced its ZORBAX RRHD 300SB-C18 1.8 micron column for UHPLC systems.
A silica reversed-phase column, it can be used for higher-order reversed-phase characterization of intact proteins and protein digests, and provide high stability down to pH 1 and up to 90 degrees C, the company said.
Thermo Fisher Scientific has launched its new Accucore HPLC column range.
Based on the company's Core Enhanced Technology, the Accucore product offers increased sensitivity and peak resolution in columns compatible with almost all HPLC instruments, Thermo said.
Waters has introduced a new application for Apple iPads that helps customers select the most appropriate Acquity UPLC sample plates, vials, and filters for their experiments.
The application allows users to enter various parameters for their experiment and then selects the most appropriate components based on those parameters, the company said.
NextGen Sciences has launched its csfdiscovery43 multiplex protein assay for the discovery and quantification of protein biomarkers linked to central nervous system diseases including Alzheimer's, Parkinson's, and multiple sclerosis.
The assays use multiple-reaction monitoring mass spectrometry to simultaneously measure proteins in cerebrospinal fluid samples.
Protea Biosciences this week introduced its new Precast Mini Gels for use with Bio-Rad and Invitrogen systems.
Available in 10, 12, and 15 percent acrylamide formulations, the gels are tested for MS compatibility and are certified MS grade, the company said.
Origene announced this week the release of 300 new TrueMAB monoclonal antibodies, bringing its total TrueMAB offerings to more than 2,700.
The antibodies come with positive controls and are validated using IHC, flow cytometry, IF, IP, and Western blotting, the company said.